Exploring the incidence of culturally responsive communication in Australian healthcare: the first rapid review on this concept

Minnican, Carla; O’Toole, Gjyn

doi:10.1186/s12913-019-4859-6

Cited by 37 publications

(58 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many countries worldwide are facing the challenge of ever-increasing pharmaceutical expenditures [ 1 , 2 , 3 , 4 ], and the global pharmaceutical market reached USD 955 billion in 2019 [ 5 ]. In China, the total pharmaceutical expenditures increased by 17 times from 1990 to 2009, with an annual growth of 15.2% [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China

Chen

Yang

Luo

et al. 2020

IJERPH

View full text Add to dashboard Cite

In 2019, the Chinese government implemented the first round of the National Centralized Drug Procurement (NCDP) pilot (so-called “4 + 7” policy) in mainland China, in which 25 drugs were included. We conducted this study to examine the impacts of NCDP policy on drug utilization and expenditures, and to clarify the main factors contributing to drug expenditure changes. This study used drug purchasing order data from the Centralized Drug Procurement Survey in Shenzhen 2019. Drugs related to the “4 + 7” policy were selected as study samples, including 23 “4 + 7” policy-related varieties and 15 basic alternative drugs. Driving factors for drug expenditures changes were analyzed using A.M. index system analysis (Addis A. & Magrini N.’ method). After the implementation of the NCDP policy, the volume of “4 + 7” policy-related varieties increased by 73.8%, among which winning products jumped by 1638.2% and non-winning products dropped by 70.8%; the expenditures of “4 + 7” policy-related varieties decreased by 36.9%. Structure effects (0.47) and price effects (0.78) negatively contributed to the increase in drug expenditures of “4 + 7” policy-related varieties, while volume effects (1.73) had positive influence. NCDP policy successfully decreased drug expenditures of “4 + 7” policy-related varieties with structure effects playing a leading role. However, total drug expenditures were not effectively controlled due to the increasing use of alternative drugs.

show abstract

Section: Introductionmentioning

confidence: 99%

The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China

Chen

Yang

Luo

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

“…This finding is not unique to our study. Minnican and O'Toole (2020) also found that community members reported health providers used complicated or patronising tones. Non-First Nations health service providers must learn to listen, speak without jargon, clarify misunderstandings, and acknowledge and accommodate the expertise of community members as ways to improve cross-cultural understanding (Minnican & O'Toole, 2020).…”

Section: Discussionmentioning

confidence: 96%

Combining First Nations Research Methods with a World Health Organization Guide to Understand Low Childhood Immunisation Coverage in Children in Tamworth, Australia

Thomas

Allan

Taylor

et al. 2021

iipj

View full text Add to dashboard Cite

In Australia, we used the World Health Organization’s Tailoring Immunization Programmes to identify areas of low immunisation coverage in First Nations children. The qualitative study was led by First Nations researchers using a strength-based approach. In 2019, Tamworth had 179 (23%) children who were overdue for immunisations. Yarning sessions were conducted with 50 parents and health providers. Themes that emerged from this research included: (a) Cultural safety in immunisation services provides a supportive place for families, (b) Service access could be improved by removing physical and cost barriers, (c) Positive stories promote immunisation confidence among parents, (d) Immunisation data can be used to increase coverage rates for First Nations children. Knowledge of these factors and their impact on families helps ensure services are flexible and culturally safe.

show abstract

“…The Evaluation of Routinely Measured Patient-reported Outcomes in Haemodialysis Care (EMPATHY) RCT, which aims to determine the effects of routine measurement of ePROMs on the experiences of patients undergoing in-centre haemodialysis in Alberta and Ontario, Canada, is currently underway. 81 The use of ePROMs in the management of patients receiving home dialysis is also being trialled in the ePRO Kidney study. 82 …”

Section: Ongoing Eprom Initiativesmentioning

confidence: 99%

A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases

Aiyegbusi

Nair

Peipert

et al. 2021

Therapeutic Advances in Chronic Disease

View full text Add to dashboard Cite

An application of telemedicine of growing interest and relevance is the use of personal computers and mobile devices to collect patient-reported outcomes (PROs). PROs are self-reports of patients’ health status without interpretation by anyone else. The tools developed to assess PROs are known as patient-reported outcomes measures (PROMs). The technological innovations that have led to an increased ownership of electronic devices have also facilitated the development of electronic PROMs (ePROMs). ePROMs are a conduit for telemedicine in the care of patients with chronic diseases. Various studies have demonstrated that the use of ePROMs in routine clinical practice is both acceptable and feasible with patients increasingly expressing a preference for an electronic mode of administration. There is increasing evidence that the use of electronic patient-reported outcome (ePROMs) could have significant impacts on outcomes valued by patients, healthcare providers and researchers. Whilst the development and implementation of these systems may be initially costly and resource-intensive, patient preferences and existing evidence to support their implementation suggests the need for continued research prioritisation in this area. This narrative review summarises and discusses evidence of the impact of ePROMs on clinical parameters and outcomes relevant to chronic diseases. We also explore recently published literature regarding issues that may influence the robust implementation of ePROMs for routine clinical practice.

show abstract

Exploring the incidence of culturally responsive communication in Australian healthcare: the first rapid review on this concept

Cited by 37 publications

References 36 publications

The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China

The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China

Combining First Nations Research Methods with a World Health Organization Guide to Understand Low Childhood Immunisation Coverage in Children in Tamworth, Australia

A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases

Contact Info

Product

Resources

About